期刊文献+

Regulatory effect of a Chinese herbal medicine formula on nonalcoholic fatty liver disease 被引量:28

Regulatory effect of a Chinese herbal medicine formula on nonalcoholic fatty liver disease
下载PDF
导出
摘要 BACKGROUND Non-alcoholic fatty liver disease(NAFLD)has become a major cause of chronic liver disease.The Chinese herbal medicine(CHM)Dachaihu decoction(DCHD)has been proved to treat NAFLD with good efficacy in previous studies.Based on the TCM principle of formula formation,we divided DCHD into soothing liver part,invigorating spleen part,and dredging intestine part.Marshall officially proposed the concept of“intestinal-hepatic axis”,which systematically explains the interactions between the intestine and liver.We hypothesized that the effect of CHM on NAFLD is achieved by regulating the liver and intestine.Thus,we aimed to investigate the possible effect of a CHM formula on NAFLD in a rat model.AIM To investigate the effects of a CHM formula(a decoction of Chinese thorowax root,scutellaria root,and white peony root)on NAFLD and its regulatory effect on the“intestinal-liver”axis.METHODS Sixty rats were randomly divided into control,model,pioglitazone hydrochloride(PH),and CHM(a decoction of Chinese thorowax root,scutellaria root,and white peony root)groups.An NAFLD rat model was established using a high-fat highfructose diet for 16 wk.From the 13th week,rats were administered with PH or a decoction of Chinese thorowax,scutellaria,and white peony root(CHM group)for 4 wk.Rats in the control group and model group were administered with an equal volume of distilled water.At the end of the study,blood was collected via the abdominal aorta.Liver tissues were harvested and any morphological changes were observed by hematoxylin-eosin(HE)staining,Oil red O staining,and Masson staining.In addition,blood lipids,liver function markers,and triglyceride(TG)in liver tissues were analyzed.The levels of transforming growth factor-β1(TGF-β1),tumor necrosis factor-α(TNF-α),Toll-like receptor-4(TLR4),and nuclear factor-kappa B(NF-кB)in liver tissues and secreted immunoglobulin A(sIgA)in intestinal tissues were analyzed by ELISA,and protein and mRNA expression of occludin and zonula occludens-1(ZO-1)in the intestine were BACKGROUND Non-alcoholic fatty liver disease(NAFLD) has become a major cause of chronic liver disease. The Chinese herbal medicine(CHM) Dachaihu decoction(DCHD)has been proved to treat NAFLD with good efficacy in previous studies. Based on the TCM principle of formula formation, we divided DCHD into soothing liver part, invigorating spleen part, and dredging intestine part. Marshall officially proposed the concept of "intestinal-hepatic axis", which systematically explains the interactions between the intestine and liver. We hypothesized that the effect of CHM on NAFLD is achieved by regulating the liver and intestine. Thus, we aimed to investigate the possible effect of a CHM formula on NAFLD in a rat model.AIM To investigate the effects of a CHM formula(a decoction of Chinese thorowax root, scutellaria root, and white peony root) on NAFLD and its regulatory effect on the "intestinal-liver" axis.METHODS Sixty rats were randomly divided into control, model, pioglitazone hydrochloride(PH), and CHM(a decoction of Chinese thorowax root, scutellaria root, and white peony root) groups. An NAFLD rat model was established using a high-fat highfructose diet for 16 wk. From the 13 th week, rats were administered with PH or a decoction of Chinese thorowax, scutellaria, and white peony root(CHM group)for 4 wk. Rats in the control group and model group were administered with an equal volume of distilled water. At the end of the study, blood was collected via the abdominal aorta. Liver tissues were harvested and any morphological changes were observed by hematoxylin-eosin(HE) staining, Oil red O staining,and Masson staining. In addition, blood lipids, liver function markers, and triglyceride(TG) in liver tissues were analyzed. The levels of transforming growth factor-β1(TGF-β1), tumor necrosis factor-α(TNF-α), Toll-like receptor-4(TLR4), and nuclear factor-kappa B(NF-кB) in liver tissues and secreted immunoglobulin A(sIgA) in intestinal tissues were analyzed by ELISA, and protein and mRNA expression of occludin and zonul
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第34期5105-5119,共15页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,No.81673868
关键词 Non-alcoholic FATTY LIVER disease Chinese HERBAL medicine LIVER function Intestinal-hepatic axis Non-alcoholic fatty liver disease Chinese herbal medicine Liver function Intestinal-hepatic axis
  • 相关文献

参考文献1

二级参考文献31

  • 1Angulo P. GI epidemiology: nonalcoholic fatty liver disease.Aliment Pharmacol Ther 2007; 25: 883-889 [PMID: 17402991DOI: 10.1111/j.1365-2036.2007.03246.x]. 被引量:1
  • 2Ibrahim MA, Kelleni M, Geddawy A. Nonalcoholic fatty liverdisease: current and potential therapies. Life Sci 2013; 92: 114-118[PMID: 23159641 DOI: 10.1016/j.lfs.2012.11.004]. 被引量:1
  • 3Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A.What are the risk factors and settings for non-alcoholic fatty liverdisease in Asia-Pacific- J Gastroenterol Hepatol 2007; 22: 794-800[PMID: 17498218 DOI: 10.1111/j.1440-1746.2007.04952.x]. 被引量:1
  • 4Paredes AH, Torres DM, Harrison SA. Nonalcoholic fatty liverdisease. Clin Liver Dis 2012; 16: 397-419 [PMID: 22541706 DOI:10.1016/j.cld.2012.03.005]. 被引量:1
  • 5Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseasesand aging: friends or foes- Aging Cell 2013; 12: 950-954 [PMID:23815295]. 被引量:1
  • 6Meli R, Mattace Raso G, Calignano A. Role of innate immuneresponse in non-alcoholic Fatty liver disease: metaboliccomplications and therapeutic tools. Front Immunol 2014; 5: 177[PMID: 24795720 DOI: 10.3389/fimmu.2014.00177]. 被引量:1
  • 7Grhage F, Nattermann J. Viral hepatitis: human genes that limitinfection. Best Pract Res Clin Gastroenterol 2010; 24: 709-723[PMID: 20955972 DOI: 10.1016/j.bpg.2010.07.009]. 被引量:1
  • 8Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, YoshiokaA, Takahashi M, Akisawa N, Iwasaki S, Oben JA, Onishi S.Angiotensin II type 1 receptor blocker inhibits fibrosis in ratnonalcoholic steatohepatitis. Hepatology 2007; 45: 1375-1381[PMID: 17518368 DOI: 10.1002/hep.21638]. 被引量:1
  • 9Serviddio G, Sastre J, Bellanti F, Vi J, Vendemiale G, AltomareE. Mitochondrial involvement in non-alcoholic steatohepatitis. MolAspects Med 2008; 29: 22-35 [PMID: 18061659 DOI: 10.1016/j.mam.2007.09.014]. 被引量:1
  • 10Kim MS, Kung S, Grewal T, Roufogalis BD. Methodologies forinvestigating natural medicines for the treatment of nonalcoholicfatty liver disease (NAFLD). Curr Pharm Biotechnol 2012; 13:278-291 [PMID: 21470125]. 被引量:1

共引文献2

同被引文献288

引证文献28

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部